Caterpillar™ Arterial Embolization Device Post-Market Study

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

August 13, 2021

Study Completion Date

August 12, 2022

Conditions
Embolization, Therapeutic
Interventions
DEVICE

Caterpillar™ Arterial Embolization Device

Placement of the Caterpillar™ Arterial Embolization Device for patients requiring arterial embolization in the peripheral vasculature.

Trial Locations (11)

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

33176

Baptist Hospital of Miami, Miami

46202

Indiana University School of Medicine, Indianapolis

53226

The Medical College of Wisconsin, Inc., Milwaukee

55455

University of Minnesota Medical Center - Fairview, Minneapolis

66160

University of Kansas Medical Center Research Institute, Kansas City

77030

University of Texas Health Science Center at Houston, Houston

78756

Cardiothoracic and Vascular Surgeons, Austin

85013

Dignity Health/St. Joseph's & Medical Center, Phoenix

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT04244370 - Caterpillar™ Arterial Embolization Device Post-Market Study | Biotech Hunter | Biotech Hunter